BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1976436)

  • 21. Practical guidelines for DNA-based testing in multiple endocrine neoplasia type 1.
    Larsson C; Nordenskjold M; Skogseid B; Oberg K
    Henry Ford Hosp Med J; 1992; 40(3-4):173-6. PubMed ID: 1362400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma.
    Larsson C; Skogseid B; Oberg K; Nakamura Y; Nordenskjöld M
    Nature; 1988 Mar; 332(6159):85-7. PubMed ID: 2894610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rare syndromes.
    Jabbour SA; Davidovici BB; Wolf R
    Clin Dermatol; 2006; 24(4):299-316. PubMed ID: 16828412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletion of chromosome 1, but not mutation of MEN-1, predicts prognosis in sporadic pancreatic endocrine tumors.
    Guo SS; Wu AY; Sawicki MP
    World J Surg; 2002 Jul; 26(7):843-7. PubMed ID: 11960210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors.
    Hessman O; Lindberg D; Einarsson A; Lillhager P; Carling T; Grimelius L; Eriksson B; Akerström G; Westin G; Skogseid B
    Genes Chromosomes Cancer; 1999 Nov; 26(3):258-64. PubMed ID: 10502325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allele loss on chromosome 10 and point mutation of ras oncogenes are infrequent in tumors of MEN 2A.
    Okazaki M; Miya A; Tanaka N; Miki T; Yamamoto M; Motomura K; Miyauchi A; Mori T; Takai S
    Henry Ford Hosp Med J; 1989; 37(3-4):112-5. PubMed ID: 2576939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer.
    Srivatsan ES; Chakrabarti R; Zainabadi K; Pack SD; Benyamini P; Mendonca MS; Yang PK; Kang K; Motamedi D; Sawicki MP; Zhuang Z; Jesudasan RA; Bengtsson U; Sun C; Roe BA; Stanbridge EJ; Wilczynski SP; Redpath JL
    Oncogene; 2002 Aug; 21(36):5631-42. PubMed ID: 12165862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial, malignant tumors of the endocrine pancreas.
    Hessman O; Lindberg D; Skogseid B; Carling T; Hellman P; Rastad J; Akerström G; Westin G
    Cancer Res; 1998 Feb; 58(3):377-9. PubMed ID: 9458074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatic mutation of the MEN1 gene in parathyroid tumours.
    Heppner C; Kester MB; Agarwal SK; Debelenko LV; Emmert-Buck MR; Guru SC; Manickam P; Olufemi SE; Skarulis MC; Doppman JL; Alexander RH; Kim YS; Saggar SK; Lubensky IA; Zhuang Z; Liotta LA; Chandrasekharappa SC; Collins FS; Spiegel AM; Burns AL; Marx SJ
    Nat Genet; 1997 Aug; 16(4):375-8. PubMed ID: 9241276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deletion of chromosome 1 predicts prognosis in pancreatic endocrine tumors.
    Ebrahimi SA; Wang EH; Wu A; Schreck RR; Passaro E; Sawicki MP
    Cancer Res; 1999 Jan; 59(2):311-5. PubMed ID: 9927038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 11q13 allelic loss in pituitary tumors in patients with multiple endocrine neoplasia syndrome type 1.
    Weil RJ; Vortmeyer AO; Huang S; Boni R; Lubensky IA; Pack S; Marx SJ; Zhuang Z; Oldfield EH
    Clin Cancer Res; 1998 Jul; 4(7):1673-8. PubMed ID: 9676841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonal analysis by chromosome 11 microsatellite-PCR of microdissected parathyroid tumors from MEN 1 patients.
    Morelli A; Falchetti A; Amorosi A; Tonelli F; Bearzi I; Ranaldi R; Tomassetti P; Brandi ML
    Biochem Biophys Res Commun; 1996 Oct; 227(3):736-42. PubMed ID: 8886003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Putative tumor-suppressor gene on chromosome 11 is important in sporadic endocrine tumor formation.
    Eubanks PJ; Sawicki MP; Samara GJ; Gatti R; Nakamura Y; Tsao D; Johnson C; Hurwitz M; Wan YJ; Passaro E
    Am J Surg; 1994 Jan; 167(1):180-5. PubMed ID: 7906100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Multiple endocrine neoplasia type 2: mapping of the gene predisposing and alteration of genotypes in tumor].
    Nishisho I; Takai S; Tateishi H; Motomura K; Okazaki M; Yamamoto M; Miki T
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):919-23. PubMed ID: 2908403
    [No Abstract]   [Full Text] [Related]  

  • 35. [Multiple endocrine neoplasia type I. Review and presentation of the study group of multiple endocrine neoplasia type I (GENEM I)].
    Saint-André JP; Berger-Dutrieux N; Le Bodic MF; de Micco C; Trouillas J
    Arch Anat Cytol Pathol; 1994; 42(2):77-82. PubMed ID: 7811118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allelotype of human thyroid tumors: loss of chromosome 11q13 sequences in follicular neoplasms.
    Matsuo K; Tang SH; Fagin JA
    Mol Endocrinol; 1991 Dec; 5(12):1873-9. PubMed ID: 1791835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low incidence of loss of chromosome 10 in sporadic and hereditary human medullary thyroid carcinoma.
    Nelkin BD; Nakamura Y; White RW; de Bustros AC; Herman J; Wells SA; Baylin SB
    Cancer Res; 1989 Aug; 49(15):4114-9. PubMed ID: 2568166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localization and identification of the multiple endocrine neoplasia type 1 disease gene.
    Larsson C; Friedman E
    Endocrinol Metab Clin North Am; 1994 Mar; 23(1):67-79. PubMed ID: 7913030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 2.8-Mb clone contig of the multiple endocrine neoplasia type 1 (MEN1) region at 11q13.
    Guru SC; Olufemi SE; Manickam P; Cummings C; Gieser LM; Pike BL; Bittner ML; Jiang Y; Chinault AC; Nowak NJ; Brzozowska A; Crabtree JS; Wang Y; Roe BA; Weisemann JM; Boguski MS; Agarwal SK; Burns AL; Spiegel AM; Marx SJ; Flejter WL; de Jong PJ; Collins FS; Chandrasekharappa SC
    Genomics; 1997 Jun; 42(3):436-45. PubMed ID: 9205115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple endocrine neoplasia (MEN)--an overview and case report--patient with sporadic bilateral pheochromocytoma, hyperparathyroidism and marfanoid habitus.
    Fassbender WJ; Krohn-Grimberghe B; Görtz B; Litzlbauer D; Stracke H; Raue F; Kaiser HE
    Anticancer Res; 2000; 20(6C):4877-87. PubMed ID: 11205236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.